SQSTM1 and diabetic cardiomyopathy: Luteolin also provide protection against diabetic cardiomyopathy by down regulation of miR‐221, p62, JNK, and c‐Jun, reduction of mitochondrial swelling, enhancing autophagic vesicles and LC3‐II/I in the diabetic heart (Xiao et al. 2023).